Bigul

Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nalanda India Equity Fund Ltd
30-06-2021
Bigul

Thyrocare tumbles 11.5% intra-day

Shares of Thyrocare Technologies plunged 11.5 per cent on Monday to 1,280.95 on the BSE during intra-day trade, as the Street gave a thumbs-down to t
28-06-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

As already reported, the 21st Annual General Meeting ('AGM') of the Company was held on June 26, 2021 at 3.00 p.m. through Video Conferencing (VC)/ Other Audio Visual Means(OAVM). All the resolutions placed before the Members were approved by them. In this regard, please find enclosed the following' 1. Voting results in the specified format, as required under Regulation 44 of the SEBI(Listing Obligations and Disclosure Requirements) Regulation 2015; 2. Report of Scrutinizer dated June 27th 2021 pursuant to the provisions of Section 108 of Companies Act 2013('Act'), read with Rule 20(4) (xii) of the Companies (Management and Administration) Rules 2014;
28-06-2021

Not insisting on board seat; only an investor: Thyrocare's A Velumani

I am an investor, and not insisting on any board seat. I am selling my entire stake of 66 per cent, says Velumani
28-06-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

Appointment of MSKA Associates (Firm No.105047W) as Auditors of the Company for a period of five years from the conclusion of the 21st AGM till the conclusion of the 26th AGM
27-06-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

Appointment of MSKA Associates (Firm No.105047W) as Auditors of the Company for a period of five years from the conclusion of the 21st AGM till the conclusion of the 26th AGM
27-06-2021
Bigul

What's in it for minority shareholders in the Thyrocare buyout

With founder exiting, the change in management could weigh heavily on investors' minds
26-06-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Shareholder Meeting / Postal Ballot-Outcome of AGM

In continuation to our letter dated 04th June, 2021, we wish to inform you that the 21st Annual General Meeting ('AGM') of the Company was held today, Saturday, the 26th June 2021, through Video Conferencing (VC) / Other Audio Video Means (OAVM). A total number of 65 shareholders attended the meeting. The meeting commenced at 3.00 p.m. and ended at 4.30 p.m. All the items of business mentioned in the Notice dated June 04, 2021, were transacted and approved. In this regard, please find enclosed the Summary of proceedings as required under Regulation 30, Part-A of Schedule -III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
26-06-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to the execution of a share purchase agreement dated 25 June 2021 between members of the promoter and promoter group of Thyrocare Technologies Limited ('Company') the Sellers have agreed to sell to the Acquirer their entire shareholding in the Company, being equivalent to approximately 66.14% of the equity share capital of the Company (on a fully diluted basis) and being equivalent to 3,49,72,999 equity shares of the Company (collectively, the 'Sale Shares'), and the Acquirer has agreed to purchase the Sale Shares from the Sellers in accordance with the share purchase agreement, completion of which is subject to certain conditions precedent ('Share Purchase Agreement').
25-06-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Open Offer

JM Financial Ltd ("Manager to Open Offer") has submitted to BSE a copy of Public Announcement for the attention of the Public Shareholders of Thyrocare Technologies Ltd ("Target Company") under Regulation 3(1) and Regulation 4 read with Regulation 15(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments Thereto.
25-06-2021
Next Page
Close

Let's Open Free Demat Account